Sumitomo Chemical Company, Limited (4005)

Name: Sumitomo Chemical Company, Limited (4005) — histórico de demonstrações financeiras
Creator: TickerBase
License: https://creativecommons.org/licenses/by/4.0/

Histórico de receita, lucros e fluxo de caixa das demonstrações financeiras oficiais.

Basic Materials · Wall Street (EUA) · Última atualização: 2026-10-02

Sumitomo Chemical Company, Limited engages in Agro & Life Solutions, ICT & Mobility Solutions, Advanced Medical Solutions, Essential & Green Materials, and Sumitomo Pharma. The Agro & Life Solutions segment offers crop protection chemicals, fertilizers, agricultural materials, household insecticides, products for control of infectious diseases, and feed additives, etc.

Números-chave

Capitalização de mercado: JPY 949 billion
Receita (exercício encerrado em 2026-03-31): JPY 2.33T
Lucro líquido: JPY 60.9B
Margem bruta: 28.7%
Margem líquida: 2.6%

Ver gráficos interativos e demonstrações completas → Modelo de avaliação (DCF) →

Demonstração de resultados anual

Demonstração de resultados	2026-03-31	2025-03-31	2024-03-31	2023-03-31
Receita total	JPY 2.33T	JPY 2.61T	JPY 2.45T	JPY 2.90T
Lucro bruto	JPY 668.3B	JPY 725.5B	JPY 499.7B	JPY 820.9B
Resultado Operacional (EBIT)	JPY 195.0B	JPY 172.4B	(JPY 431.4B)	(JPY 24.2B)
Resultado líquido	JPY 60.9B	JPY 38.6B	(JPY 311.8B)	JPY 7.0B

Fonte: relatórios públicos da empresa (SEC). Verifique no SEC EDGAR antes de confiar em qualquer número.

Balanços, fluxos de caixa, dados trimestrais e indicadores completos no visualizador interativo de 4005. /companies/us/4005

Empresas semelhantes

As informações deste site são apenas educacionais e informativas; não constituem recomendação de investimento. Não publicamos preços-alvo nem recomendações.

English version →Todas as ações

About TickerBase · Data methodology & sources · Privacy · Terms

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.